Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
ABSTRACT A novel type of antibacterial screening method, a target mechanism-based whole-cell screening method, was developed to combine the advantages of target mechanism- and whole-cell-based approaches. A mycobacterial reporter strain with a synthetic phenotype for caseinolytic protease (ClpP1P2)...
Main Authors: | Wilfried Moreira, Grace J. Y. Ngan, Jian Liang Low, Anders Poulsen, Brian C. S. Chia, Melgious J. Y. Ang, Amelia Yap, Justina Fulwood, Umayal Lakshmanan, Jolander Lim, Audrey Y. T. Khoo, Horst Flotow, Jeffrey Hill, Ravikiran M. Raju, Eric J. Rubin, Thomas Dick |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2015-07-01
|
Series: | mBio |
Online Access: | https://journals.asm.org/doi/10.1128/mBio.00253-15 |
Similar Items
-
Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome
by: Thomas Dick, et al.
Published: (2017-04-01) -
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
by: Yoshiyuki Yamada, et al.
Published: (2017-04-01) -
Caseinolytic proteases of Lactobacillus and Lactococcus strains isolated from fermented dairy products
by: Jasna Novak, et al.
Published: (2022-01-01) -
Caseinolytic proteases of Lactobacillus and Lactococcus strains isolated from fermented dairy products
by: Jasna Novak, et al.
Published: (2022-01-01) -
Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential
by: Heike Brötz-Oesterhelt, et al.
Published: (2021-05-01)